The Radiation Oncology Case Rate Value Based Program Act (ROCR) creates a new Medicare value‑based payment program that bundles radiation therapy billing into unified per‑episode payments and adds a narrowly defined payment to support transportation for patients with transportation insecurity. It tasks CMS with rulemaking to establish rates, accreditation and quality requirements, and reporting while excluding ROCR‑related savings from statutory budget‑neutrality adjustments.
Why this matters: ROCR would change how radiation therapy is paid under Part B by shifting from encounter or per‑service payments to episode payments, adding a specific equity incentive tied to transportation, and carving those savings out of budget‑neutrality offsets — a combination that could materially affect revenue flows for hospital outpatient departments, freestanding centers, physician groups, and Medicare’s spending trajectory.
At a Glance
What It Does
The bill requires the Secretary of HHS to create a Radiation Oncology Case Rate Value Based Payment Program (ROCR) that pays consolidated per‑episode amounts for defined radiation therapy episodes and establishes program rules, accreditation and quality incentives, and a targeted health‑equity add‑on for transportation. It also directs CMS to use notice‑and‑comment rulemaking and exempts ROCR’s savings from statutory budget‑neutrality adjustments and from certain payment program interactions.
Who It Affects
Medicare Part B beneficiaries receiving radiation therapy and the providers who furnish it — hospital outpatient departments, freestanding radiation centers, and physician group practices — are directly affected; CMS, accreditation organizations, and vendors of radiation technology and patient transportation services will also see operational impacts. The bill excludes Medicare Advantage enrollees and PACE participants from ROCR.
Why It Matters
Consolidating payment into episodes changes revenue timing and incentives — favoring efficiency and shorter courses of care, while accreditation and quality rules steer clinical standards. The statutory carve‑out from budget‑neutrality rules removes a normal fiscal check on payment redesigns, making ROCR a potentially significant precedent for future Medicare payment reforms.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The ROCR Act directs CMS to write rules, via formal notice‑and‑comment, establishing a nationwide value‑based payment program for radiation oncology. CMS must do that within a year of enactment and publish both an advanced notice and a proposed rule with at least 60 days for comments.
Under the program, a defined ‘‘episode of care’’ begins with a radiation therapy planning trigger and covers a set period (longer for standard courses; shorter for bone and brain metastases). Providers that furnish the episode receive a unified payment intended to cover both professional and technical components.
Payment mechanics are detailed. CMS will set national base rates using specific M‑Code references from the November 16, 2021 Federal Register as the starting point and adjust them annually for inflation and geographically.
Rates will be rebased or revised through rulemaking every five years with a statutory cap limiting reductions via rebasing to no more than 1 percent every five years. The bill also establishes mechanisms to handle incomplete episodes, to allow concurrent payments for certain modalities, and to provide transitional payments for emerging services like adaptive radiation therapy planning until CMS assigns codes and values.To promote access and equity, the statute creates a ‘‘health equity achievement in radiation therapy’’ add‑on tied to transportation insecurity (ICD‑10 code Z59.82).
The add‑on is paid to the entity delivering the technical component and requires intake screening, documentation that the funds were used for transportation, and retention of that documentation for five years. The bill limits the add‑on’s scope (non‑air, non‑luxury transport) and bars it from replacing other federal or state transportation programs.Quality and accreditation matter under ROCR.
Providers must be accredited or in the process of accreditation by recognized radiation oncology accrediting organizations (or meet alternate audit standards if designated as ‘‘limited resource’’ providers). The statute creates a short‑term technical payment bonus for accredited participants and a later payment reduction for providers that fail to meet the standards, while carving out a capped subset of ‘‘limited resource’’ providers from harsher penalties.
Finally, ROCR requires CMS to exempt participating providers from certain Merit‑Based Incentive Payment System (MIPS) obligations and directs the Comptroller General to issue reports on access, rural ‘‘radiation therapy deserts,’’ and program effects at specified intervals.
The Five Things You Need to Know
CMS must promulgate ROCR rules through notice‑and‑comment within 1 year and provide both an advanced notice and a proposed rule with at least 60 days for comments.
Per‑episode payments are split: CMS pays one‑half prospectively (no later than 30 days after the first delivery of treatment) and the remaining half at the end of the course or at a statutory cap (90 days for most episodes; 30 days for bone and brain metastases), with expedited settlement if the patient dies.
Beneficiary coinsurance equals 20 percent of the episode payment and providers may offer multi‑installment payment plans for that coinsurance, but may not use such plans as a marketing tool.
The health‑equity transportation add‑on pays $500 per episode in year one (the first year after regulations take effect), rising by $10 annually thereafter, is triggered by ICD‑10 Z59.82 via an intake question, and requires 5‑year documentation that the add‑on was spent on non‑air transportation.
New radiation technologies and services are excluded from the national base rates for 12 years after identification; until then they are paid under the applicable existing Medicare payment system, and rebasing of base rates cannot reduce rates by more than 1 percent every 5 years.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Program establishment and rulemaking requirements
This subsection directs the Secretary to create the ROCR Program and to promulgate implementing regulations via formal notice‑and‑comment rulemaking, including an advanced notice of proposed rulemaking and proposed rule with no less than 60 days for comments. It also prevents CMS from lowering existing physician fee schedule or outpatient prospective payment rates for radiation therapy during the period between enactment and the ROCR regulations’ effectiveness, forcing a clean regulatory start date for the episode model.
Per‑episode payment structure and timing
Defines how per‑episode payments operate: CMS must set a per‑episode amount that covers professional and technical services, pay half prospectively within 30 days, and pay the remainder at the end of the course or at statutory time limits (90 days for most episodes; 30 days for bone/brain metastases). It mandates identical episode payments across sites of service and specifies that incomplete episodes revert to traditional fee schedules.
National base rates, updates, and new‑technology rules
Establishes starting national base rates tied to the M‑Code table from the November 16, 2021 Federal Register, requires annual inflation updates and five‑year rebasing or revisions via rulemaking, and caps net rebasing reductions to 1 percent every five years. New technologies are excluded from the base rates for 12 years, receive transitional or separate payments until code/value development, and must meet CMS criteria before incorporation.
Coinsurance, payment plans, and beneficiary protections
Fixes beneficiary coinsurance at 20 percent of the episode payment (subject to Part B rules), allows providers to offer multi‑installment payment plans for that coinsurance but prohibits using payment plan availability as a marketing tool, and prescribes the coinsurance calculation for incomplete episodes.
Participation rules and significant hardship exemption
Makes participation mandatory for radiation therapy providers/suppliers furnishing covered treatment to Medicare Part B beneficiaries, but permits opt‑out for entities already in state‑based CMMI models and provides a case‑by‑case hardship exemption (e.g., natural disasters) with a regulatory process for applications.
Health equity transportation add‑on
Creates a discrete add‑on payment to the technical component provider when transportation insecurity (ICD‑10 Z59.82) is documented via intake screening. The add‑on is intended for non‑air, non‑luxury transport, is paid to the technical provider, requires five‑year documentation on how funds were used, and does not change beneficiary coinsurance.
Accreditation, quality incentives, and limited‑resource exceptions
Requires accreditation by recognized radiation oncology organizations (or equivalent external audits for designated limited‑resource providers), mandates certified EHR compliance consistent with MIPS exceptions, offers a short‑term technical payment increase for accredited providers, and imposes a later payment reduction for non‑accredited providers while exempting and capping limited‑resource designation at no more than 10 percent of providers.
Reporting requirements and definitions
Directs the Comptroller General to produce a rural access report within three years and a comprehensive evaluation seven years post‑enactment (including program effects, access, and recommendations). Subsection (j) supplies detailed definitions that operationalize episodes, included cancer types, trigger codes, professional vs technical components, and the list of cancers in scope.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Medicare Part B beneficiaries with transportation insecurity — the bill creates a targeted add‑on and explicitly allows free or discounted non‑ambulance transport to help complete courses of radiation therapy.
- Accredited radiation oncology providers and suppliers — they receive initial technical payment increases and a clearer, unified revenue stream per episode, reducing payment volatility from per‑service fee schedules.
- Patients in areas with nearby radiation capacity — the episode design and accreditation emphasis aim to encourage efficient, local delivery and potentially reduce disparities in access by aligning incentives with shorter, high‑value courses of therapy.
Who Bears the Cost
- Centers for Medicare & Medicaid Services — statutory exclusion of ROCR savings from budget neutrality adjustments and new payment flows increase administrative and fiscal exposure and require new rate‑setting, auditing, and oversight work.
- Small and resource‑constrained radiation providers — accreditation, certified EHR requirements, and participation mechanics impose up‑front compliance costs; limited‑resource designation is available but capped (no more than 10 percent).
- Beneficiaries — the law preserves a 20 percent coinsurance on episode payments, which may leave some patients with substantial out‑of‑pocket liability unless providers offer affordable payment plans; coinsurance is explicitly unchanged by the transportation add‑on.
Key Issues
The Core Tension
The bill’s core dilemma is balancing stable, episode‑level payments that encourage efficiency, local access, and equity interventions (transportation), against protecting innovation, preventing under‑treatment, and maintaining Medicare’s fiscal discipline — a design that stabilizes provider revenue but risks slowing adoption of costly new therapies and loosening the budgetary check that normally accompanies payment reform.
ROCR bundles numerous trade‑offs into a single statute. The move to per‑episode payments stabilizes predictable revenue and rewards efficiency, but it also creates downside pressure to shorten or simplify courses of therapy; without strong, well‑designed quality measures and monitoring, episode payments can incentivize under‑provision or avoidance of complex patients.
The bill responds with accreditation and a delayed penalty/reward structure, but the standards, audit processes, and how CMS will weigh quality versus cost in practice are left to regulation.
The five‑year rebasing rule with a 1 percent cap on reductions and a 12‑year exclusion for new technologies create divergent incentives. Providers get payment stability, and new technology suppliers face a prolonged window where their innovations are paid outside of the episode base rates — a protection for providers but a potential disincentive for rapid diffusion of clinically beneficial, but costly, technology.
The statutory carve‑out that prevents CMS from applying usual budget‑neutral offsets to ROCR savings reduces the fiscal constraint that normally forces contemporaneous adjustments elsewhere in Medicare; that could accelerate adoption but also increase program spending unless CMS tightens savings adjustments within ROCR itself.
Operationally, the transportation add‑on and the CMP exception are tightly detailed but administratively demanding: the ICD‑10 screening trigger, 5‑year documentation requirement, and the rule that transportation must be borne by the eligible entity or funded by the technical provider (and not shifted to federal programs) will require enforceable audit trails. The limits on marketing and driver compensation aim to reduce abuse, yet enforcement is resource‑intensive.
Unresolved questions include the exact specifications for limited‑resource status and the 10 percent cap, the mechanism for calculating the ‘‘savings adjustment’’ within the payment model, and how the model will interact with clinical trial participation, multi‑disciplinary cancer care, and Medicare Advantage plans where many oncology patients are enrolled.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.